Page last updated: 2024-12-07

1,3-diethyl-2-thiobarbituric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,3-Diethyl-2-thiobarbituric acid (DTB) is a chemical compound that is used in research to measure the level of lipid peroxidation, a process that occurs when lipids are damaged by free radicals.

Here's a breakdown of its significance in research:

**What it is:**

* **Structure:** DTB is a heterocyclic compound containing a thiobarbituric acid ring, which is modified with two ethyl groups attached at positions 1 and 3.
* **Reactivity:** DTB reacts with malondialdehyde (MDA), a major product of lipid peroxidation. This reaction forms a colored complex that can be measured spectrophotometrically.

**Why it's important in research:**

* **Lipid peroxidation marker:** DTB is a widely used marker for lipid peroxidation, a process that can damage cell membranes, proteins, and DNA, leading to various diseases and conditions.
* **Assessing oxidative stress:** Lipid peroxidation is a major component of oxidative stress, which is linked to aging, cancer, cardiovascular disease, and neurodegenerative disorders.
* **Monitoring experimental interventions:** Researchers use DTB to monitor the effectiveness of antioxidants, anti-inflammatory agents, and other interventions aimed at reducing oxidative stress and lipid peroxidation.
* **Understanding disease mechanisms:** DTB helps scientists understand the role of lipid peroxidation in various diseases and develop new therapeutic strategies.

**Limitations:**

* **Specificity:** DTB can react with other compounds besides MDA, leading to potential overestimation of lipid peroxidation.
* **Sensitivity:** The DTB assay may not be sensitive enough to detect low levels of lipid peroxidation.

**Conclusion:**

1,3-Diethyl-2-thiobarbituric acid (DTB) is a valuable tool for researchers studying oxidative stress and lipid peroxidation. It provides a convenient and relatively straightforward method to quantify lipid peroxidation levels in various biological samples. While it has some limitations, DTB remains a widely used marker in a broad range of research areas.

1,3-diethyl-2-thiobarbituric acid: used in urinary test for smoking [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID78890
CHEMBL ID2136061
SCHEMBL ID1033205
MeSH IDM0133620

Synonyms (44)

Synonym
EN300-18198
bxb40m6a7w ,
unii-bxb40m6a7w
1,3-diethyl-2-thioxodihydropyrimidine-4,6(1h,5h)-dione
nsc158284
barbituric acid,3-diethyl-2-thio-
5217-47-0
mls003106467 ,
1,3-diethyl-2-thiobarbituric acid
n,n'-diethyl-2-thiobarbituric acid
n,n'-diethylthiobarbituric acid
nsc-158284
1,3-diethylthiobarbituric acid
4,5h)-pyrimidinedione, 1,3-diethyldihydro-2-thioxo-
1,3-diethyl-2-thiobarbituric acid, 99%
4,6(1h,5h)-pyrimidinedione, 1,3-diethyldihydro-2-thioxo-
1,3-diethyldihydro-2-thioxopyrimidine-4,6(1h,5h)-dione
nsc 158284
einecs 226-010-7
barbituric acid, 1,3-diethyl-2-thio-
inchi=1/c8h12n2o2s/c1-3-9-6(11)5-7(12)10(4-2)8(9)13/h3-5h2,1-2h3
shbtugjakbrbbj-uhfffaoysa-
smr001821370
1,3-diethyl-2-sulfanylidene-1,3-diazinane-4,6-dione
AKOS000119446
STK201353
1u6 ,
SCHEMBL1033205
CHEMBL2136061
1,3-diethyl-2-thioxodihydro-4,6(1h,5h)-pyrimidinedione #
DTXSID0022222
J-803024
3-[3-(piperidin-1-ylmethyl)pheno xy]propan-1-amine oxalic acid salt
SR-01000311815-1
sr-01000311815
mfcd00006676
Z57354986
1,3-diethyl-2-thiobarbituricacid
CS-0204337
1.3-diethyl-2-thiobarbituric acid
Q27274941
SB58150
BS-28659
F87998
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
WRNHomo sapiens (human)Potency56.23410.168331.2583100.0000AID651768
hypothetical protein, conservedTrypanosoma bruceiPotency31.62280.223911.245135.4813AID624173
serine/threonine-protein kinase PLK1Homo sapiens (human)Potency6.70160.168316.404067.0158AID720504
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (14.29)18.7374
1990's4 (28.57)18.2507
2000's2 (14.29)29.6817
2010's5 (35.71)24.3611
2020's1 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.42 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]